RAC 0.93% $1.62 race oncology ltd

Well it did have a crystalisation problem that's why we needed...

  1. 5,612 Posts.
    lightbulb Created with Sketch. 1280
    Well it did have a crystalisation problem that's why we needed RC220.
    To my understanding Rc110 still could be used by going into a main artery with fast blood flow to get through to the heart and it took a few hours to administer.
    Still worked well but it was just not practical enough.
    but now the team has solved that problems lucky for us Shareholders,
    but not so lucky for all the people it could of saved if the old owners in the 80s solved the problem and made the reformulation as we have.
    At least we know for a fact RC110 helped some people and they are still alive till this day and had families.
    Now with RC220 being a better version it will help people all over the world.
    This stock definitely out of all I have ever bought has the most meaning and funny enough the most upside.
    I really can't wait for the first patient to start the trial.
    Great thing are coming our way
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.